camptothecin has been researched along with Cancer of Eye in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janavs, JL; Pierce, ME; Takahashi, JS | 1 |
| Cheson, BD; Phillips, PH; Wilson, WH | 1 |
| Enomoto, T; Murata, Y; Nakajima, Y; Nakamura, T | 1 |
3 other study(ies) available for camptothecin and Cancer of Eye
| Article | Year |
|---|---|
RNA synthesis inhibitors increase melatonin production in Y79 human retinoblastoma cells.
Topics: Amidohydrolases; Anisomycin; Arylamine N-Acetyltransferase; Calcium; Camptothecin; Colforsin; Cyclic AMP; Dactinomycin; Dopamine; Egtazic Acid; Eye Neoplasms; Humans; Melatonin; Nerve Tissue Proteins; Protein Synthesis Inhibitors; Retinoblastoma; Topoisomerase I Inhibitors; Transcription, Genetic; Tumor Cells, Cultured | 1994 |
Clinical trials at the medicine branch of the NCI-part 2.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Central Nervous System Neoplasms; Clinical Trials as Topic; Eye Neoplasms; Humans; Immunotherapy; Lymphoma; Lymphoma, Non-Hodgkin; Recurrence | 1995 |
Loss of one allele of the p53 gene in the lens epithelial tumor in transgenic mice suppresses apoptosis induced by a topoisomerase I inhibitor (CPT-11).
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Eye Neoplasms; Genotype; In Situ Nick-End Labeling; Irinotecan; Lens, Crystalline; Mice; Mice, Transgenic; Topoisomerase I Inhibitors; Tumor Suppressor Protein p53 | 2002 |